Who owns Sunlenca?
Sunlenca is owned by Gilead (the United States, NASDAQ: GILD).[1]
Evidence: Gilead Sciences, Inc. Annual Report on Form 10-K filed 2026-02-24, SEC EDGAR, 24 February 2026. Verified from filings; last checked .
Key facts
- Current owner
- Gilead Sciences, Inc. verified
- Owner HQ
- 🇺🇸 United States, Foster City
- Origin
- 🇺🇸 United States
- Category
- Healthcare & pharma › Drug makers › Biotechnology
- Parent ticker
- NASDAQ: GILD
- Last verified
- · 1 sources
About Sunlenca
Sunlenca is an HIV-1 capsid inhibitor sold as a tablet and as a subcutaneous injection, given twice a year to heavily treatment-experienced adults whose multidrug-resistant HIV-1 is failing their current regimen. It is one of the HIV products in Gilead's 2025 10-K.
Ownership timeline of Sunlenca
Where Sunlenca sits in Gilead
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Gilead ownership tree →
See the full Gilead brand portfolio (9) →
Other brands owned by Gilead
Gilead controls 9 brands on Brandtree, 9 of them in healthcare & pharma.
Also in healthcare & pharma
Other brands in drug makers, and who owns them
Gilead has more brands in drug makers on Brandtree than any other owner: 5 of 24.
About the owner: Gilead
Gilead is a publicly listed company headquartered in Foster City, United States. Brandtree records 9 brands under its control, and it is listed as NASDAQ: GILD.
Gilead Sciences is a Delaware-incorporated biopharmaceutical company headquartered in Foster City, California. Its 10-K for 2025 says its commercial portfolio included more than 25 therapies in HIV, liver disease, oncology and other areas, sold through marketing subsidiaries in more than 35 countries, and records a 2020 acquisition of Immunomedics and the October 2025 acquisition of Interius BioTherapeutics.
🇺🇸 Sunlenca and other American brands
Brandtree records a controlling owner for 2,399 brands that began in the United States. 461 of them (19%) are now controlled by a company headquartered in another country; Sunlenca is not one of them.
Frequently asked questions
Who is the parent company of Sunlenca?
The parent company of Sunlenca is Gilead, a publicly listed company headquartered in the United States.
Is Sunlenca American?
Yes. Sunlenca originated in the United States and its owner, Gilead, is also headquartered in the United States.
Is Sunlenca still owned by Gilead?
Yes. As of 14 October 2026, Sunlenca is still owned by Gilead. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Gilead Sciences, Inc. Annual Report on Form 10-K filed 2026-02-24 — SEC EDGAR, SEC Form 10-K, published 24 February 2026; retrieved 14 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.